Ligand Pharmaceuticals Incorporated
Hedge Funds Holdings
Last updated:
Ligand Pharmaceuticals Incorporated‘s stocks are currently a part of 136 hedge funds’ portfolios, which represents 59.53% of the total amount of its stocks outstanding. This makes up a total of 10.01M shares of Ligand Pharmaceuticals Incorporated. Compared to the previous quarter, the number fell by -35.37% or -5.48M shares fewer. As for the holding position changes, 26.47% (36) of current hedge fund investors increased the number of shares held, 40.44% (55) of current holders sold a part of the shares held, and 13.24% (18) closed the holdings completely. 15 hedge funds are new holders of Ligand Pharmaceuticals Incorporated stock in Q2 2022, it is 11.03% of total holders.
Hedge funds holding Ligand Pharmaceuticals Incorporated (Q3 2017 – Q2 2022)
| Q3 2017 | 288 |
|---|---|
| Q4 2017 | 294 |
| Q1 2018 | 321 |
| Q2 2018 | 340 |
| Q3 2018 | 380 |
| Q4 2018 | 354 |
| Q1 2019 | 324 |
| Q2 2019 | 302 |
| Q3 2019 | 272 |
| Q4 2019 | 261 |
| Q1 2020 | 257 |
| Q2 2020 | 257 |
| Q3 2020 | 248 |
| Q4 2020 | 233 |
| Q1 2021 | 224 |
| Q2 2021 | 206 |
| Q3 2021 | 200 |
| Q4 2021 | 212 |
| Q1 2022 | 194 |
| Q2 2022 | 136 |
Hedge funds changes in Ligand Pharmaceuticals Incorporated positions (Q3 2017 – Q2 2022)
| Q3 2017 | 50 | 114 | 81 | 19 | 24 |
|---|---|---|---|---|---|
| Q4 2017 | 38 | 123 | 95 | 30 | 8 |
| Q1 2018 | 60 | 94 | 129 | 26 | 12 |
| Q2 2018 | 41 | 123 | 129 | 20 | 27 |
| Q3 2018 | 68 | 101 | 166 | 24 | 21 |
| Q4 2018 | 59 | 157 | 91 | 85 | -38 |
| Q1 2019 | 45 | 118 | 123 | 71 | -33 |
| Q2 2019 | 32 | 92 | 136 | 49 | -7 |
| Q3 2019 | 20 | 74 | 130 | 51 | -3 |
| Q4 2019 | 29 | 59 | 130 | 33 | 10 |
| Q1 2020 | 44 | 68 | 109 | 44 | -8 |
| Q2 2020 | 38 | 80 | 113 | 35 | -9 |
| Q3 2020 | 30 | 90 | 97 | 38 | -7 |
| Q4 2020 | 29 | 80 | 90 | 45 | -11 |
| Q1 2021 | 38 | 55 | 105 | 44 | -18 |
| Q2 2021 | 18 | 71 | 76 | 35 | 6 |
| Q3 2021 | 17 | 71 | 71 | 23 | 18 |
| Q4 2021 | 29 | 70 | 81 | 14 | 18 |
| Q1 2022 | 18 | 66 | 77 | 36 | -3 |
| Q2 2022 | 15 | 36 | 55 | 18 | 12 |
Hedge funds changes in Ligand Pharmaceuticals Incorporated stock options (Q3 2017 – Q2 2022)
| Q3 2017 | 11,246,000 | 19,253,000 |
|---|---|---|
| Q4 2017 | 7,109,000 | 18,170,000 |
| Q1 2018 | 9,607,000 | 12,756,000 |
| Q2 2018 | 27,459,000 | 19,392,000 |
| Q3 2018 | 59,936,000 | 28,822,000 |
| Q4 2018 | 106,233,000 | 146,795,000 |
| Q1 2019 | 61,657,000 | 121,962,000 |
| Q2 2019 | 53,360,000 | 83,875,000 |
| Q3 2019 | 36,573,000 | 199,937,000 |
| Q4 2019 | 75,577,000 | 140,308,000 |
| Q1 2020 | 47,392,000 | 80,465,000 |
| Q2 2020 | 39,069,000 | 139,452,000 |
| Q3 2020 | 12,698,000 | 119,594,000 |
| Q4 2020 | 33,086,000 | 173,145,000 |
| Q1 2021 | 54,239,000 | 107,648,000 |
| Q2 2021 | 33,448,000 | 13,302,000 |
| Q3 2021 | 3,220,000,023,333,000 | 285,000,008,119,000 |
| Q4 2021 | 24,898,000 | 6,476,000 |
| Q1 2022 | 7,210,000 | 3,442,000 |
| Q2 2022 | 1,347,000 | 80,000 |